Komipharm International Co., Ltd. (KOSDAQ: 041960)

Komipharm International Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 9, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	275,106	293,942	446,056	548,450	858,749	969,689
Market Cap Growth	-34.03%	-34.10%	-18.67%	-36.13%	-11.44%	-17.31%
Enterprise Value	310,140	324,970	476,056	565,527	878,631	994,115
Last Close Price	3950.00	4190.00	6350.57	7804.20	12219.61	13854.95
PE Ratio	81.11	-73.51	-68.29	-122.64	-304.71	-45.36
PS Ratio	5.39	6.89	11.21	15.30	23.11	27.32
PB Ratio	4.57	4.90	6.79	7.57	11.00	12.73
P/FCF Ratio	-401.13	-85.53	-167.97	-265.03	-526.68	-202.49
P/OCF Ratio	-8214.93	-104.98	-246.74	-436.69	34076.71	1019.87
EV/Sales Ratio	6.04	7.62	11.96	15.78	23.64	28.01
EV/EBITDA Ratio	76.88	-118.44	21308.58	-331.06	561.53	-630.67
EV/EBIT Ratio	401.82	-51.80	-125.15	-106.89	-403.99	-182.93
EV/FCF Ratio	-430.87	-94.56	-179.27	-273.29	-538.87	-207.59
Debt / Equity Ratio	0.69	0.75	0.58	0.46	0.46	0.54
Debt / EBITDA Ratio	10.83	-	1706.78	-	22.80	-
Debt / FCF Ratio	-60.68	-13.12	-14.36	-16.15	-21.88	-8.54
Asset Turnover	0.43	0.37	0.35	0.30	0.30	0.27
Inventory Turnover	2.19	1.93	1.87	1.77	1.83	1.90
Quick Ratio	0.58	0.52	0.53	0.93	0.72	1.05
Current Ratio	1.04	0.96	1.01	1.61	1.14	1.51
Return on Equity (ROE)	3.97%	-9.41%	-10.84%	-7.89%	-5.13%	-26.72%
Return on Assets (ROA)	0.42%	-3.40%	-2.09%	-2.79%	-1.10%	-2.56%
Return on Capital (ROIC)	0.48%	-3.75%	-2.27%	-3.01%	-1.18%	-2.71%
Earnings Yield	1.23%	-1.35%	-1.46%	-0.81%	-0.33%	-2.20%
FCF Yield	-0.26%	-1.17%	-0.60%	-0.38%	-0.19%	-0.49%
Buyback Yield / Dilution	0.13%	0.18%	-0.01%	-0.09%	-0.37%	-0.13%
Total Shareholder Return	0.13%	0.18%	-0.01%	-0.09%	-0.37%	-0.13%

Source: S&P Capital IQ. Standard template. Financial Sources.